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Abstract: Reactive oxygen intermediates (RO!), re-
active nitrogen intermediates (RNI), and cytokines
are frequent companions at sites of acute inflamma-
tion. Previous work has established a clear link
between the production of cytokines and the sub-
sequent generation of ROt and RN!. However, more
recent data indicates that ROt and RN! not only serve
as end-stage effector molecules of pathogen destruc-
tion and tissue injury, but also as initiators of acute
inflammation. Specifically, RO! and RN! will up-
regulate cytokine gene expression since antioxidants
inhibit interleukin 8 (IL-8) production and do not
decrease production of other cytokines. Treatment
with hydroxyl radical scavengers such as dimethyl
sulfoxide (DMSO) will decrease the production of
!L-8 in stimulated human whole blood, fibroblasts,
type !! epithelial cells, and hepatoma cells, but not
other cytokines. Addition of exogenous ROl will
increase !L-8 production in these same cells. Inhibi-
tion of nitric oxide synthase will decrease production
of !L-8, whereas addition of nitric oxide (NO)-gen-
erating compounds will increase production of IL-8.
The hydroxyl radical appears to be the final common
pathway of cell activation for IL-8 synthesis, since
DMSO will inhibit the NO-driven production of!L-8.
Our data indicate that HO! and RN! can serve as
intracellular second messengers to induce IL-8 gene
expression. J. Leukoc. Biol. 59: 471-475; 1996.
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Recruitment and activation of neutrophils
The recruitment of neutrophils (PMNs) to sites of active
inflammation remains a poorly defined process. Certain
cytokines have been associated with neutrophil recruit-
ment, such as tumor necrosis factor (TNF) or interleukin-l
(IL-i) [1], but careful experimentation has shown that they
attract neutrophils through the induction of another newly
translated protein mediator [2]. Interleukin-8 (IL-8) repre-
sents a newly described cytokine [3] and is a potent in-
ducer of neutrophil chemotaxis. It is produced early in
inflammation as a direct result of interaction of cells with
such stimuli as endotoxin [4], and it will also be further
up-regulated by the early, alarm cytokines such as TNF
and IL-i [5, 6]. Interestingly, a single dose of lipopolysac-
charide (LPS) will serve to induce continuing production
of IL-8 protein and persisting levels of IL-8 mRNA in vitro
[5]. This finding stands in contrast to most other cytokines,
where the mRNA rapidly disappears [7], and the protein
levels plateau after a few hours [8]. There is now ample
evidence that IL-8 has the ability to persist for several days
during inflammatory states. Therefore, there is a theoreti-
cal basis and published data to support a role for IL-8 as
the recruiter of neutrophils to sites of inflammation.
Reactive oxygen intermediates (ROl), reactive nitrogen
intermediates (RNI), and tissue injury are also frequent
companions at sites of acute inflammation (reviewed in
refs. 9 and 10). The accepted hypothesis that links these
observations may be stated as follows: PMNs are recruited
to sites of acute inflammation; once at the site, they pro-
duce substantial quantities of ROIs [ii, 12], which, to-
gether with released proteases [13], injure the tissue.
However, ROI/RNI may serve a completely different func-
tion in acute inflammation, where they do not operate
solely as end-stage effector molecules, but also as media-
tors regulating cytokine gene expression. RO!s have in fact
been shown to be important inducers of both prokaryotic
and eukaryotic gene expression by activation of various
transcription factors including oxyR and nuclear factor-
KB, respectively [14]. The predicted sequence is as fol-
lows: low intracellular concentrations of ROl and RNI
serve to up-regulate expression of IL-8, which then in-
duces neutrophil chemotaxis. This hypothesis does not in
any way contradict previous work concerning ROI/RNIs
and tissue damage [15-17], it merely expands their in-
flammatory role as initiators of the cascade that elicits
neutrophils. Our data demonstrates an intimate link be-
tween the production of ROl, RNI, and the generation of
neutrophil chemoattractants.
Abbreviations: ROl, reactive oxygen intermediates; RNI, reactive ni-
trogen intermediates; IL, interleukin; DMSO, dimethyl sulfoxide; NO,
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chronic granulomalous disease; L-NAME, (L-N-nitroarginine methyl
ester.
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BIOCHEMISTRY OF THE FORMATION OF AOl
AND RNI
There have been several studies detailing the capacity of
cytokines to induce ROl and RNI formation from a variety
of cell types. Numerous cytokines have been demonstrated
to enhance ROl and/or RN! production including TNF,
IL-i, IL-6, IL-8, interferon-y, and granulocyte-macrophage
colony-stimulating factor. The metabolic intermediates and
enzymes important in formation and degradation of ROIs
have been defined [ii, 18] and these pathways are shown
schematically in Figure 1. The major ROl produced
within the cell are the superoxide (02) anion, hydrogen
peroxide (H202), and the hydroxyl radical (OH). There are
several compounds that may be used to dissect the various
pathways involved in RO! formation, including the antioxi-
dant hydroxyl radical scavengers [dimethyl sulfoxide
(DMSO), dimethyl thiourea, thiourea, etc.]. Another anti-
oxidant defense mechanism is to maintain high intracellu-
lar levels of glutathione, which will effectively scavenge
the RO!.
RNIs, the most widely studied of which is nitric oxide
(NO), are ultimately formed from the enzymatic generation
of the highly reactive NO by the family of enzymes called
NO synthases (NOS) [19]. There are three different iso-
forms of NOS identified to date. All three isoforms produce
NO from the terminal guanidino group of L-arginine. Two
of the isoforms are Ca2/calmodulin-dependent and are
constitutively produced (ecNOS and ncNOS). In contrast,
the third isoform (iNOS) is Ca2/calmodulin-independent
and is inducible by treatment of cells with cytokines or
microbial products [10]. NO can combine with ROIs to
form other RNIs, such as nitrogen dioxide (NO2), peroxyni-
trite (0N00), and the hydroxyl radical [20, 21]. Under
physiological conditions, NO readily complexes with pro-
tein-bound transition metal ions or thiol groups forming
iron-nitrosyl proteins or S-nitrosoproteins, respectively.
From a biological standpoint, these complexes have been
implicated to be responsible for the involvement of NO in
such diverse processes as neurotransmission, vasodilata-
tion, platelet inhibition, host defense, and inflammation.
ROI AND THE INDUCTION OF CYTOKINES
Our laboratory has extensively studied the regulation of
cytokine gene expression by ROl. We have shown that
inhibition of ROl will decrease IL-8 production, and that
augmentation of ROl will enhance IL-8 production [22,
23]. We have specifically been testing the hypothesis that
low level intracellular formation of ROl will serve as sec-
ond messengers for the induction of IL-8 gene expression.
Our first experiments evaluated human whole blood
stimulated with 100 nglml of LPS. LPS is a potent stimulus
that will induce the production of several cytokines . As
can be observed in Figure 2, LPS stimulation for 24 h
results in a substantial increase in IL-8 detectable in the
plasma. Unstimulated samples have 0.6 ± 0.2 ng/ml of
Fig. 1. Metabolic pathways of ROl and RNI. The major pathways
involved in the generation of ROl and RNI, as well as the inhibitors that
will block their production: (Reproduced with permission from ref. 22).
IL-8, and LPS stimulation increases this amount to 4.0 ±
1.0 nglml (mean ± SE for 3 individuals). Addition of 1%
DMSO immediately prior to the LPS stimulation caused a
significant reduction in the amount of IL-8 (1.8 ± 1.0
ng/ml, P< 0.05 compared with LPS). To demonstrate that
the inhibition of IL-8 was specific and not merely due to
loss of cell viability, IL-6 was measured in these same
samples. As can be observed, there was no reduction in the
amount of IL-6 by DMSO. These results have been ex-
tremely consistent in our laboratory and have been ob-
served reproducibly in dozens of volunteers over the past
years. In human whole blood, IL-8 production is inhibited
by oxygen radical scavengers, whereas that of IL-6 and
other cytokines is not. We sought to determine whether the
inhibition of IL-8 occurred at the transcriptional or trans-
lational level by performing Northern blot analysis. LPS
results in a substantial increase in mRNA coding for IL-8,
whereas DMSO causes a reduction in mRNA expression
(data not shown). There are several other stimuli that will
serve to induce the formation of IL-8, including phytohe-
magglutinin, immune complexes, and recombinant cytoki-
nes such as TNF or IL-i [23]. Regardless of the stimulus
that is used in the whole blood, DMSO will decrease the
production of IL-8, and this inhibition occurs at the level
of the mRNA.
The biochemistry of ROl formation is complex and many
different reactive intermediates may be responsible for the
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Fig. 2. Antioxidant inhibition of IL-8 production. Human whole blood
was stimulated with 100 ng/ml of LPS in the presence or absence of 1%
DMSO, and cytokines in the plasma measured 24 h later. DMSO caused
a significant reduction in the amount of IL-8, with no reduction in the
amount of IL-6. Values are means ± SE. 5P< 0.05 compared to LPS.
using several different inhibitors in LPS-stimulated whole
blood. All of the hydroxyl radical scavengers that were
tested effectively decreased the production of IL-8. The
order of potency of inhibition, listed from most potent to
least potent was (concentration in parenthesis): dimethyl
thiourea (75 mM) > ethanol (86 mM) > DMSO (140 mM)
> thiourea (75 mM) > mannitol (50 mM). The addition of
catalase or superoxide dismutase (SOD) did not block the
production of IL-8. These results may appear paradoxical,
since the hydroxyl radical is formed through superoxide or
hydrogen peroxide. However, our hypothesis states that it
is intracellular levels of ROI that drive the reaction. The
large catalase and SOD enzymes will not penetrate the cell
to achieve sufficiently high concentrations to alter intracel-
lular levels of ROl unless steps are taken to modify the
enzymes to improve their bioavailability [24]. Deferox-
amine will chelate iron and prevent the Fenton reaction
(H202 - OH) from occurring, however, addition of defer-
oxamine did not reduce IL-8. This may well be due to the
whole blood system that we use, which has very high iron
binding capacity.
We further explored the source of the ROIs in LPS-
stimulated whole blood by using other inhibitors. Allopuri-
nol and oxypurinol will inhibit xanthine oxidase and
prevent the formation of superoxide. Neither of these in-
hibitors effectively decreased IL-8 production. Superoxide
is also formed through the action of NADPH oxidase, and
this enzyme is deficient in patients with chronic granu-
lomatous disease (CGD) [25]. When whole blood from pa-
tients with CGD is stimulated with LPS,
phytohemagglutinin, immune complexes, or IL-i, there is
an up-regulation of IL-8, which is inhibitable by 1%
DMSO [22]. This indicates that the ROI are not formed
through the action of NADPH oxidase. All of these data
would point to the mitochondria as the source of the super-
oxide, which is consistent with publications indicating that
mitochondria may serve as a source of ROl [26, 27].
All of the data presented until this time have dealt with
scavenging of ROl and decreasing IL-8. We also evaluated
whether addition of exogenous ROl would increase the
production of IL-8. H2O2 was added directly to human
whole blood where it caused a substantial increase in the
amount of IL-8, and this increase was inhibitable by
DMSO [23]. These results again point to the importance of
ROI as regulators of cytokine gene expression.
Our studies were extended to isolated, cultured cells to
determine whether other cell types also exhibited regula-
tion of IL-8 by ROI. Isolated human fibroblasts were incu-
bated in the presence of glucose oxidase (5 mU/ml) and the
supernatants collected at different time points (Fig. 3).
Glucose oxidase caused a substantial increase in the IL-8
concentration in the supernatant, which could be inhibited
by the addition of catalase. In this setting, the glucose
oxidase is generating H2O2 in the extracellular media,
which will diffuse into the cell to up-regulate IL-B. Be-
cause the ROl is generated outside of the cell, catalase has
the opportunity to inactivate the H2O2 before it moves into
the cell. This is in contrast to the LPS-stimulated whole
blood, where catalase is not effective because the ROl are
generated within the cell. Other cell lines were tested for
their ability to produce IL-B in response to exogenous RO!.
Fibroblasts, hepatoma cells (HEP-G2) and type II alveolar
epithelial cells (A549) all secrete IL-B into the supernatant
when stimulated with 1% H202, and this induction could
be inhibited by the addition of catalase [22].
Other investigators have examined the ability of ROl to
serve as intracellular second messengers [28]. A recent
publication has supported our concept concerning the role
Fig. 3. Kinetics of glucose oxidase induction of lL-8 in cultured fi-
broblasts. Glucose oxidae added to the media of cultured human fi-
broblasts induces the synthesis of IL-8. This could be completely
prevented by the addition of catalase, which will metabolize H2O2. Values
are means ± SE for triplicate wells. No stimulus, catalase alone, and
catalase plus glucose oxidase failed to induce up-regulation of IL-8.
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of ROI in the induction of chemokine expression with data
showing that antioxidants will also depress production of
monocyte chemotactic protein [29]. In the monocyte cell
line U937, antioxidants will prevent the up-regulation of
TNF [30]. In contrast, our studies did not show any signifi-
cant inhibition of TNF using stimulated whole blood. The
differences probably relate to the experimental conditions,
since the whole blood contains substantial oxidant scav-
enging capacity. In this regard, experiments in our labora-
tory have shown that the production of TNF by isolated
human mononuclear cells may be inhibited by 1% DMSO
(unpublished data). A report has shown that the stress
induced by exposure to a heavy metal, cadmium, will in-
duce IL-8 in isolated human mononuclear cells [31]. Our
work with fibroblasts failed to show that cadmium would
induce IL-8 [22]. Additional studies in vivo have shown
that steps to maintain the intracellular levels of glutathione
will inhibit TNF production and decrease mortality [32]. In
this setting, there is a severe stress (i.e., lethal LPS) and
the intracellular stores of glutathione are not sufficient to
prevent substantial accumulation of ROIs.
RNI INDUCTION OF CYTOKINES
Our studies demonstrating the strong regulatory effect of
OH on IL-B production led us to explore the possibility
that RNIs may also exert similar effects on cytokine pro-
duction. We explored this hypothesis because NO has
been shown to be involved in intracellular signaling as well
as OH formation (Fig. 1) [19]. These experiments were
designed to parallel those used in examining the regulation
of cytokine gene expression by ROIs. The availability of
NO synthase inhibitors and NO-generating compounds
have made it possible to evaluate the effect of NO in regu-
lating cytokine gene expression. Thus far, our studies have
provided ample evidence substantiating an immunoregula-
tory role for NO in IL-B production in the human whole
blood system and in the human endothelial cell line,
ECV3O4.
Figure 4 depicts a representative set of data from one
donor showing the LPS (1 tg/ml) -induced increase in both
IL-B (18.8 ng/ml) and IL-6 (87.8 ng/ml). Addition of 5mM
L-N-nitroarginine methyl ester (L-NAME), a NO synthase
inhibitor, to blood 2 h before LPS stimulation resulted in
the substantial decrease in IL-B but not IL-6 protein levels.
This inhibitory effect of L-NAME was dose-dependent and
also occurred at the mRNA level. The observation that NO
synthase inhibitors have the potential to inhibit IL-B pro-
duction in human whole blood has been extended to the
human endothelial cell line, ECV3O4. TNF is a potent
inducer of IL-B in endothelial cells [33]. Stimulation of
ECV3O4 cells with 50 nglml of TNF induced significant
levels of IL-8, which was inhibited in a dose-dependent
manner by the addition of L-NAME [34].
The next series of experiments was used to evaluate
whether exogenously added NO could stimulate cytokine
production in the whole blood model or the ECV3O4 cells.
Fig. 4. Inhibition of NO synthase decreases IL-8 production. Human
whole blood was stimulated with 1 I.lgf ml of LPS in the presence or absence
of 5 mM L-NAME, and cytokines in the plasma measured 24 h later.
Blockade of NO synthase resulted in a reduction in the amount of IL-8,
with no reduction in the amount of IL-6. Data are from a single donor but
are representative of >15 individual donors. When the groups are com-
pared, 5 mM L-NAME causes a significant inhibition of IL-8 production.
*P< 0.05 compared to LPS.
Studies were conducted using ethanamine-2,2’-(hy-
droxynitrosohydrazono)bis (DETA NONOate, Cayman
Chemical, Ann Arbor, MI), a spontaneous NO generator.
DETA NONOate added to either whole blood or the
ECV3O4 cells resulted in a dose-dependent increase in
IL-8. Addition of 10 mM DETA NONOate to whole blood,
or 2 mM to ECV3O4 cells, was able to induce significant
levels of IL-B after 24 h incubation. IL-B levels continually
increased up to 72 h after the addition of 10 mM DETA
NONOate to the whole blood. No measurable IL-6 was
detected in the same samples.
As discussed above, oxidant stress, particularly that
caused by OH, appears to represent one of the signals that
causes up-regulation of IL-B gene transcription. Interest-
ingly, one of the intracellular pathways that leads to OH
formation involves the formation of peroxynitrite from the
rapid reaction of NO with 02- (Fig. 1). With this in mind,
the results from a representative experiment displayed in
Table 1 show the effect of L-NAME and the OH scaven-
ger, DMSO, on DETA NONOate or H2O2-induced IL-B
production in whole blood. Consistent with our previous
reports, 0.15% H202 induced IL-8 production, which was
significantly reduced by 1% DMSO [22]. Since L-NAME is
a substrate competitor for L-arginine and does not have any
known direct scavenging effect on radicals, it is not sur-
prising that IL-B production by either DETA NONOate or
H2O2 was not inhibited. However, addition of DMSO to
DETA NONOate-stimulated blood dramatically sup-
pressed IL-B production compared with the sample treated
with the stimulant alone. These results strongly indicate a
potentially important link between 0H and NO induction
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TABLE 1. Effect of L-NAM
I





(concentration) No treatment + i-NAME + DMSO
Control 1.5 2.5 ND
DETA NONOate (10 mM) 10.3 10.5 1.8
11202 (0.15%) 4.7 4.9 0.9
Human whole blood was stimulated as indicated and IL-B measured 24 h later.
ND, not done.
of IL-B production in human whole blood, since the hy-
droxyl radical may he mediating the action of NO.
CONCLUSIONS
ROI and RNI are formed within the cytoplasm following
stimulation of cells. These intracellular ROI and RNI may
serve as second messengers to up-regulate expression of
cytokines, and IL-B is particularly sensitive to these
changes. Blockade of NO synthase or scavenging of hy-
droxyl radicals will decrease the formation of IL-B and
addition of exogenous RNI or ROI will increase gene ex-
pression of IL-B. Our data point to a new role for these
intracellular reactive species, as regulators of the immune
response by augmenting cytokine gene expression. There
is an important causal link between the formation of NO
and the generation of hydroxyl radicals leading to the in-
duction of cytokine gene expression.
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